当前位置:首页 - 行情中心 - 上海医药(601607) - 财务分析 - 现金流量表

上海医药

(601607)

  

流通市值:506.24亿  总市值:673.07亿
流通股本:27.89亿   总股本:37.08亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金148,688,702,663.6970,910,161,157.29301,138,074,959.71216,241,126,794.79
  收到的税费返还106,985,906.8838,238,102.29157,075,769.86161,365,821.57
  收到其他与经营活动有关的现金2,295,146,319.361,393,974,548.043,355,474,894.373,014,000,050.91
  经营活动现金流入小计151,090,834,889.9372,342,373,807.62304,650,625,623.94219,416,492,667.27
  购买商品、接受劳务支付的现金133,530,822,206.4165,775,005,547.17268,134,361,085.34192,621,520,661.57
  支付给职工以及为职工支付的现金5,836,065,054.482,607,855,464.0410,639,199,652.276,829,300,693.72
  支付的各项税费3,962,697,333.331,773,546,369.287,327,044,163.215,770,527,692.3
  支付其他与经营活动有关的现金6,771,993,306.824,390,282,030.3412,722,762,991.7911,412,179,163.42
  经营活动现金流出小计150,101,577,901.0474,546,689,410.83298,823,367,892.61216,633,528,211.01
  经营活动产生的现金流量净额989,256,988.89-2,204,315,603.215,827,257,731.332,782,964,456.26
二、投资活动产生的现金流量:
  收回投资收到的现金36,312,602,00015,723,939,00047,809,428,496.4117,454,567,000
  取得投资收益收到的现金169,259,831.4538,474,527.841,346,951,721.68971,322,262.61
  处置固定资产、无形资产和其他长期资产收回的现金净额67,276,784.1912,714,792.84244,660,546.13159,079,166.98
  处置子公司及其他营业单位收到的现金净额16,865,471.7915,892,367.13-12,364,306.65
  收到的其他与投资活动有关的现金1,125,180,875.51667,562,153.291,032,193,865.93756,787,587.49
  投资活动现金流入小计37,691,184,962.9416,458,582,841.150,433,234,630.1519,354,120,323.73
  购建固定资产、无形资产和其他长期资产支付的现金1,124,571,482.54729,965,333.272,400,874,817.191,835,291,094.2
  投资支付的现金36,028,414,84016,032,179,00045,933,887,00015,857,397,000
  取得子公司及其他营业单位支付的现金626,709,265.2618,657,072.8485,292,225.3493,692,695.4
  支付其他与投资活动有关的现金1,151,755,000650,718,8401,597,200,887.931,209,757,790.34
  投资活动现金流出小计38,931,450,587.817,431,520,246.1150,017,254,930.4618,996,138,579.94
  投资活动产生的现金流量净额-1,240,265,624.86-972,937,405.01415,979,699.69357,981,743.79
三、筹资活动产生的现金流量:
  吸收投资收到的现金7,378,175.77,378,175.786,196,122.618,315,022.81
  取得借款收到的现金35,773,622,565.6820,071,815,783.1261,928,229,561.8545,513,265,721.35
  发行债券收到的现金5,997,825,0002,998,941,666.6711,997,222,500.018,997,610,000.01
  收到其他与筹资活动有关的现金176,698,086.4174,562,727.69137,374,213.51654,648,042.46
  筹资活动现金流入小计41,955,523,827.7823,252,698,353.1874,149,022,397.9755,183,838,786.63
  偿还债务支付的现金36,315,299,38818,625,809,410.4570,102,029,449.9450,540,691,452.41
  分配股利、利润或偿付利息支付的现金1,347,824,733.59590,654,622.244,309,892,169.513,431,566,587.4
  其中:子公司支付给少数股东的股利、利润488,040,452.9183,402,958.44706,216,464.59310,114,905.19
  支付其他与筹资活动有关的现金539,022,568.43172,025,454.51,601,031,157.181,074,804,786.25
  筹资活动现金流出小计38,202,146,690.0219,388,489,487.1976,012,952,776.6355,047,062,826.06
  筹资活动产生的现金流量净额3,753,377,137.763,864,208,865.99-1,863,930,378.66136,775,960.57
四、汇率变动对现金及现金等价物的影响-13,772,678.984,038,703.532,156,741.31-22,872,683.73
五、现金及现金等价物净增加额3,488,595,822.81690,994,561.34,381,463,793.673,254,849,476.89
  加:期初现金及现金等价物余额31,881,272,794.8731,881,272,794.8727,499,809,001.227,499,809,001.2
  期末现金及现金等价物余额35,369,868,617.6832,572,267,356.1731,881,272,794.8730,754,658,478.09
补充资料:
  净利润4,994,784,030.29-5,870,011,314.88-
  资产减值准备410,078,463.89-614,373,564.47-
  固定资产和投资性房地产折旧767,496,142.84-1,294,305,848.92-
  无形资产摊销255,283,712.67-399,940,491.39-
  长期待摊费用摊销98,405,948.12-191,100,283.87-
  处置固定资产、无形资产和其他长期资产的损失-39,986,393.32--187,967,998.85-
  公允价值变动损失-75,751,833.73--203,853,796.87-
  财务费用894,866,769.55-1,837,342,811.14-
  投资损失-3,353,837,518.88--593,000,866.77-
  递延所得税572,280,216.64--110,038,272.1-
  其中:递延所得税资产减少-41,775,560.74-89,329,045.05-
    递延所得税负债增加614,055,777.38--199,367,317.15-
  存货的减少-727,190,985.67--2,297,647,988.62-
  经营性应收项目的减少-7,208,369,490.15--4,041,023,805.03-
  经营性应付项目的增加3,633,443,202.94-2,103,001,583.06-
  现金的期末余额35,369,868,617.68-31,881,272,794.87-
  减:现金的期初余额31,881,272,794.87-27,499,809,001.2-
  现金及现金等价物的净增加额3,488,595,822.81-4,381,463,793.67-
公告日期2025-08-292025-04-292025-03-282024-10-30
审计意见(境内)标准无保留意见
TOP↑